“Stable expression of human cytochrome P450 1B1 in V79 Chinese hamster cells and metabolically catalyzed DNA adduct formation of dibenzo [a, l] pyrene”, Chemical research in toxicology, vol. 11, pp. 686–695, 1998.
“Mutations induced by (?)-anti-11R,12S-dihydrodiol 13S,14R-epoxide of dibenzo[a,l]pyrene in the coding region of the hypoxanthine phosphoribosyltransferase (Hprt) gene in Chinese hamster V79 cells”, Environmental and Molecular Mutagenesis, vol. 41, no. 2, pp. 131 - 139, 2003.,
“The level of DNA modification by (+)-syn-(11S, 12R, 13S, 14R)-and (–)-anti-(11R, 12S, 13S, 14R)-dihydrodiol epoxides of dibenzo [a, l] pyrene determined the effect on the proteins p53 and p21WAF1 in the human mammary carcinoma cell line MCF-7”, Carcinogenesis, vol. 20, pp. 859–865, 1999.,
“Formation of stable DNA adducts and apurinic sites upon metabolic activation of bay and fjord region polycyclic aromatic hydrocarbons in human cell cultures”, Chemical research in toxicology, vol. 13, pp. 10–17, 2000.,
“Formation of stable adducts and absence of depurinating DNA adducts in cells and DNA treated with the potent carcinogen dibenzo [a, l] pyrene or its diol epoxides”, Proceedings of the National Academy of Sciences, vol. 94, pp. 13542–13547, 1997.,
“Effects of the (–)-anti-11R, 12S-dihydrodiol 13S, 14R-epoxide of dibenzo [a, l] pyrene on DNA adduct formation and cell cycle arrest in human diploid fibroblasts”, Carcinogenesis, vol. 22, pp. 161–169, 2001.,